Anorexia Nervosa: Symptoms, Causes, Diagnosis, and Evidence-Based Treatment

Anorexia nervosa is a serious and potentially life-threatening eating disorder characterized by three core features: restriction of energy intake leading to significantly low body weight, an intense fear of gaining weight or persistent behavior that interferes with weight gain, and a disturbance in how one experiences one's body weight or shape. It is not a lifestyle choice, a phase, or a matter of vanity — it is a complex psychiatric illness with profound medical, psychological, and social consequences.

The DSM-5-TR classifies anorexia nervosa into two subtypes:

• Restricting type: Weight loss is achieved primarily through dieting, fasting, or excessive exercise. The person has not engaged in recurrent episodes of binge eating or purging during the current episode.
• Binge-eating/purging type: The person engages in recurrent episodes of binge eating or purging behaviors (such as self-induced vomiting or misuse of laxatives or diuretics) during the current episode, in addition to restriction.

This distinction matters clinically because the binge-eating/purging subtype carries additional medical risks, including electrolyte disturbances and esophageal damage, and may require somewhat different treatment approaches.

According to the DSM-5-TR, the 12-month prevalence of anorexia nervosa among young females is approximately 0.4%. The disorder is significantly more common in females than males, with a female-to-male ratio estimated at roughly 10:1 in clinical samples, though emerging research suggests that anorexia nervosa in males is substantially underdiagnosed and underreported.

Anorexia nervosa most commonly develops during adolescence and young adulthood, with peak onset typically occurring between the ages of 14 and 18. However, it can develop at any age, including in children and older adults. Historically, the disorder was considered most prevalent among white, affluent females in Western societies, but robust epidemiological research has challenged this assumption — anorexia nervosa occurs across all racial, ethnic, and socioeconomic groups.

Among psychiatric illnesses, anorexia nervosa carries one of the highest mortality rates. Research consistently estimates the standardized mortality ratio at approximately 5 to 6 times that of the general population, with causes of death including medical complications of starvation, cardiac events, and suicide.

Anorexia nervosa affects virtually every organ system and presents with behavioral, psychological, and physical symptoms. Recognizing early warning signs is critical because early intervention is strongly associated with better outcomes.

Behavioral warning signs include:

• Marked restriction of food intake — skipping meals, eating very small portions, eliminating entire food groups
• Ritualistic eating behaviors such as cutting food into tiny pieces, eating extremely slowly, or rearranging food on the plate
• Excessive or compulsive exercise, often continuing despite injury, illness, or exhaustion
• Avoidance of eating in social settings
• Frequent body checking — weighing, measuring, mirror gazing — or the opposite, complete avoidance of mirrors and scales
• Wearing loose or layered clothing to hide weight loss or stay warm
• Social withdrawal and increasing isolation
• Cooking elaborate meals for others while not eating

Psychological symptoms include:

• Intense, persistent fear of weight gain that does not diminish even as weight decreases
• Overvaluation of weight and shape as the primary or sole basis of self-worth
• Body image disturbance — perceiving oneself as overweight despite being underweight
• Denial of the seriousness of low body weight
• Cognitive rigidity, difficulty concentrating, and indecisiveness (often secondary to malnutrition)
• Depressed mood, irritability, and anxiety

Physical signs and medical complications include:

• Significant and rapid weight loss or failure to make expected developmental weight gains in children and adolescents
• Bradycardia (resting heart rate below 60 bpm) and hypotension (low blood pressure) — both indicators of medical instability
• Amenorrhea (loss of menstrual period) or irregular periods, though the DSM-5-TR no longer requires amenorrhea for diagnosis
• Lanugo — fine, downy hair growth on the body, a physiological response to heat loss
• Cold intolerance, bluish discoloration of fingers and toes
• Dizziness, fainting, and fatigue
• Dry, yellowish skin and brittle nails
• Constipation and abdominal pain
• Electrolyte instability — particularly dangerous shifts in potassium, sodium, and phosphate that can cause cardiac arrhythmias and sudden death

It is essential to understand that a person does not need to appear emaciated to have anorexia nervosa. The DSM-5-TR recognizes atypical anorexia nervosa (classified under Other Specified Feeding or Eating Disorder) in which all criteria are met except that the individual's weight is within or above the normal range despite significant weight loss. The medical and psychological consequences of atypical anorexia nervosa can be equally severe.

Anorexia nervosa does not have a single cause. It arises from a complex interplay of genetic, neurobiological, psychological, and sociocultural factors. Current research supports a biopsychosocial model in which vulnerability is shaped by biology and activated by environmental triggers.

Genetic and neurobiological factors:

• Twin studies consistently show heritability estimates of 50–60% for anorexia nervosa, indicating a substantial genetic contribution.
• Genome-wide association studies (GWAS) have identified genetic correlations between anorexia nervosa and other psychiatric conditions (such as obsessive-compulsive disorder and major depressive disorder) as well as metabolic traits, suggesting that anorexia nervosa is both a psychiatric and metabolic disorder.
• Neuroimaging research indicates differences in brain circuits involved in reward processing, interoception (the ability to sense internal body signals), and cognitive control in individuals with anorexia nervosa.
• Dysregulation of serotonin and dopamine systems has been implicated, though it remains difficult to separate cause from consequence of malnutrition.

Psychological risk factors:

• Perfectionism and high personal standards
• Trait anxiety and harm avoidance
• Low self-esteem and negative self-evaluation
• Cognitive rigidity — difficulty shifting thinking styles or adapting to change
• History of childhood anxiety disorders, particularly obsessive-compulsive features

Sociocultural and environmental factors:

• Exposure to thin-ideal media messaging and weight stigma
• Participation in activities or professions that emphasize leanness (such as ballet, gymnastics, modeling, wrestling, or distance running)
• Dieting — one of the strongest proximal risk factors for the onset of eating disorders
• Experiences of bullying, teasing about weight, or trauma, including sexual abuse
• Family dynamics characterized by high conflict, enmeshment, or overcontrol, though research cautions against blaming families — families are now understood as essential allies in treatment

It is worth emphasizing that no single factor is sufficient to cause anorexia nervosa. Many people are exposed to thin-ideal messaging or experience dieting without developing the disorder. The illness emerges when biological vulnerability intersects with psychological and environmental pressures.

Diagnosis of anorexia nervosa is made by a qualified clinician — typically a psychiatrist, psychologist, or physician with expertise in eating disorders — based on a comprehensive clinical evaluation. The DSM-5-TR specifies three diagnostic criteria:

• Criterion A: Restriction of energy intake relative to requirements, leading to a significantly low body weight in the context of age, sex, developmental trajectory, and physical health.
• Criterion B: Intense fear of gaining weight or of becoming fat, or persistent behavior that interferes with weight gain, even though at a significantly low weight.
• Criterion C: Disturbance in the way in which one's body weight or shape is experienced, undue influence of body weight or shape on self-evaluation, or persistent lack of recognition of the seriousness of the current low body weight.

The DSM-5-TR also includes severity specifiers based on body mass index (BMI) for adults: mild (BMI ≥ 17), moderate (BMI 16–16.99), severe (BMI 15–15.99), and extreme (BMI < 15). For children and adolescents, BMI percentile is used instead.

Screening tools can help identify individuals who may benefit from a full evaluation. The SCOFF questionnaire is a widely used, validated five-question screening tool. A score of 2 or more positive responses warrants follow-up clinical assessment. However, screening tools are not diagnostic instruments — they flag concern but cannot confirm or rule out a diagnosis.

A thorough diagnostic evaluation should also include:

• A detailed medical assessment including vital signs, blood work (complete metabolic panel, complete blood count, thyroid function, and other tests as indicated), and electrocardiogram (ECG)
• Assessment for medical instability — bradycardia, hypotension, electrolyte disturbances, and hypothermia are red flags that may require urgent medical stabilization
• Psychiatric assessment for co-occurring conditions such as depression, anxiety, obsessive-compulsive disorder, and suicidality
• Evaluation of nutritional status and eating behaviors

Rule-out considerations are an important part of diagnosis. Clinicians must distinguish anorexia nervosa from medical conditions that cause weight loss, such as hyperthyroidism, inflammatory bowel disease, celiac disease, or malignancy. Another key differential is Avoidant/Restrictive Food Intake Disorder (ARFID), which involves food avoidance or restriction but without the body image disturbance or fear of weight gain that defines anorexia nervosa.

Effective treatment for anorexia nervosa requires a multidisciplinary approach that addresses medical stabilization, nutritional rehabilitation, and psychological recovery. Treatment intensity ranges from outpatient therapy to full medical hospitalization, depending on the severity of illness and degree of medical compromise.

For adolescents:

Family-Based Treatment (FBT), also known as the Maudsley approach, is the most strongly supported treatment for adolescents with anorexia nervosa. FBT empowers parents to take an active role in supporting their child's nutritional recovery. The treatment proceeds in three phases: weight restoration (with parents managing meals), gradual return of eating autonomy to the adolescent, and addressing general adolescent development. Multiple randomized controlled trials have demonstrated the superiority of FBT over individual therapy for adolescents with anorexia nervosa.

For adults:

The evidence base for adult treatment is less definitive, but several approaches have demonstrated efficacy:

• Cognitive-Behavioral Therapy enhanced (CBT-E): A transdiagnostic treatment developed by Christopher Fairburn that targets the overvaluation of eating, shape, and weight, as well as the maintaining mechanisms of the eating disorder. CBT-E addresses dietary restriction, body checking, and interpersonal difficulties in a structured, individualized format.
• Specialist Supportive Clinical Management (SSCM): Combines clinical management of eating disorder symptoms (including nutritional counseling and weight monitoring) with supportive psychotherapy. Research has shown SSCM performs comparably to more specialized therapies in some trials.
• Maudsley Anorexia Nervosa Treatment for Adults (MANTRA): A cognitive-interpersonal approach that addresses maintaining factors such as cognitive rigidity, emotional avoidance, pro-anorexia beliefs, and unhelpful interpersonal patterns.
• Focal Psychodynamic Therapy: Has shown efficacy in some European trials and addresses the emotional and relational meaning of the eating disorder.

Nutritional rehabilitation is a foundational component of all treatment approaches. Weight restoration improves cognitive function, mood, and the ability to engage in psychological treatment. Refeeding must be medically supervised, particularly in severely malnourished individuals, because of the risk of refeeding syndrome — a potentially fatal condition involving dangerous shifts in fluids and electrolytes (especially phosphate) when nutrition is reintroduced too rapidly.

Pharmacotherapy: No medication has demonstrated robust efficacy as a primary treatment for anorexia nervosa. Unlike bulimia nervosa, where SSRIs have an established role, antidepressants have not been shown to produce significant weight gain or reduce core anorexia nervosa symptoms. However, medications may be used to manage co-occurring conditions such as depression, anxiety, or obsessive-compulsive symptoms. Emerging research is investigating olanzapine for its potential modest effect on weight gain and anxiety reduction, though evidence remains mixed.

Higher levels of care — including intensive outpatient programs, partial hospitalization (day programs), residential treatment, and inpatient hospitalization — are indicated when outpatient treatment is insufficient, medical instability is present, or there is acute psychiatric risk including suicidality.

Recovery from anorexia nervosa is possible, but it is often a prolonged and nonlinear process. Research on long-term outcomes generally follows the "rule of thirds": approximately one-third of individuals achieve full recovery, one-third achieve partial recovery with residual symptoms, and one-third experience a chronic or treatment-resistant course. However, more recent studies with longer follow-up periods suggest somewhat more optimistic outcomes, with recovery rates approaching 60–70% over 20 or more years.

Factors associated with a better prognosis include:

• Younger age at onset
• Shorter duration of illness before treatment
• Early weight restoration
• Strong family support and engagement in treatment (particularly for adolescents)
• Absence of binge-purge behaviors
• Fewer co-occurring psychiatric conditions

Factors associated with a poorer prognosis include:

• Longer duration of untreated illness
• Very low BMI at presentation
• Presence of purging behaviors
• Co-occurring psychiatric conditions, particularly obsessive-compulsive disorder, substance use disorders, or personality disorders
• Severe family conflict or limited social support

Relapse is common, particularly in the first one to two years following treatment. Research estimates that relapse rates range from 25% to 50%, underscoring the importance of sustained follow-up care, relapse prevention planning, and ongoing monitoring even after weight restoration is achieved. Recovery extends far beyond weight normalization — it involves resolving the psychological disturbances around body image and self-worth, developing adaptive coping strategies, and rebuilding social and occupational functioning.

It is also critical to address the long-term medical consequences of anorexia nervosa. Even after recovery, some individuals experience lasting effects such as reduced bone mineral density (osteopenia or osteoporosis), dental damage (in those with purging behaviors), fertility difficulties, and structural brain changes, though many of these complications improve with sustained nutritional rehabilitation.

Anorexia nervosa frequently co-occurs with other psychiatric conditions. Understanding these comorbidities is important because they affect treatment planning and outcomes.

• Major Depressive Disorder: Depression is the most common comorbidity, occurring in an estimated 40–60% of individuals with anorexia nervosa. However, many depressive symptoms improve significantly with weight restoration, making it essential to reassess mood after nutritional rehabilitation.
• Anxiety Disorders: Generalized anxiety disorder, social anxiety disorder, and specific phobias are highly prevalent. Importantly, anxiety disorders often predate the onset of the eating disorder, suggesting they may represent a vulnerability factor.
• Obsessive-Compulsive Disorder (OCD): There is substantial overlap between anorexia nervosa and OCD, both phenotypically (rigidity, ritualistic behavior, perfectionism) and genetically. Research estimates that 15–30% of individuals with anorexia nervosa also meet criteria for OCD.
• Bulimia Nervosa: Diagnostic crossover between anorexia nervosa and bulimia nervosa is common. Research shows that approximately 30–50% of individuals with anorexia nervosa will develop bulimic features over the course of their illness.
• Avoidant/Restrictive Food Intake Disorder (ARFID): While ARFID is a key differential diagnosis, some individuals may have had ARFID-like presentations (selective eating, sensory sensitivities around food) in childhood before developing anorexia nervosa.
• Substance Use Disorders: These are more common in the binge-eating/purging subtype than the restricting subtype.
• Personality Disorders: Particularly avoidant and obsessive-compulsive personality features are common, though personality assessment should be conducted cautiously during acute starvation, as malnutrition amplifies personality pathology.
• Post-Traumatic Stress Disorder (PTSD): A significant minority of individuals with anorexia nervosa report histories of trauma, and the co-occurrence of PTSD complicates treatment and recovery.

If you or someone you care about is exhibiting patterns consistent with anorexia nervosa — significant restriction of food intake, preoccupation with weight and body shape, rapid weight loss, or medical symptoms like dizziness, fainting, or loss of menstrual periods — it is important to seek a professional evaluation as soon as possible. Early intervention is one of the strongest predictors of a favorable outcome.

Seek immediate emergency medical care if any of the following are present:

• Fainting, seizures, or chest pain
• Heart rate below 50 beats per minute or irregular heartbeat
• Inability to stand due to dizziness or weakness
• Suicidal thoughts or self-harm behaviors
• Rapid, severe weight loss or refusal of all food and fluids
• Signs of severe dehydration (dark urine, absence of urination, extreme thirst)

Where to start:

• A primary care physician can conduct an initial medical assessment and provide referrals to eating disorder specialists.
• A psychiatrist or psychologist with expertise in eating disorders can provide comprehensive diagnostic evaluation and evidence-based treatment.
• The SCOFF questionnaire can be a useful self-screen, but it is not a substitute for professional evaluation. If you score 2 or more, discuss your concerns with a healthcare provider.
• The National Eating Disorders Association (NEDA) helpline and the Crisis Text Line are accessible resources for individuals seeking guidance on how to access care.

It is equally important for parents, partners, friends, coaches, and teachers to take warning signs seriously. People with anorexia nervosa often do not recognize — or may actively deny — the severity of their condition. Approaching the person with concern and compassion, rather than blame or criticism, and encouraging professional evaluation can be a life-saving intervention.

Recovery is possible at any stage of illness. Even individuals with longstanding anorexia nervosa can achieve meaningful improvement in health, quality of life, and psychological well-being with appropriate treatment and support.